Nanostructured Lipid Carrier-Mediated Transdermal Delivery System of Glibenclamide for Gestational Diabetes: Pharmacokinetic and Pharmacodynamic Evaluation

Ashwini M Preethi SudheerBharani S Sogali

Published in: Current drug delivery (2024)

Transdermal patches incorporating NLCs hold promise for enhancing glibenclamide's therapeutic efficacy in GDM treatment. Improved skin permeation, sustained drug release, and enhanced bioavailability make NLC-based transdermal patches a potential alternative with better patient compliance.

Keyphrases

drug release
drug delivery
case report
soft tissue
risk assessment
climate change
deep learning
smoking cessation